Electronic Journal of General Medicine

• Malhotra-Kumar S, Lammens C, Martel A, et al. Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium. J Antimicrob Chemother 2004;53(2):271–6.
• Gibbons RJ, and Houte JV. Bacterial adherence in oral microbial ecology. Ann Rev Microbiol 1975;29:19-42.
• Socransky S, Haffajee A, Cugini M, Smith C and Kent RJ. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-44.
• Bouvet A. Invasive infections by Streptococcus viridans (oral streptococci) excluding pneumococci. Presse Med 1997;26:1768-73.
• Ruoff KL. Miscellaneous catalase-negative, Grampositive cocci; emerging opportunists. J Clin Microbiol 2002;40:1129-33.
• Ruoff KL, Whiley RA and Beighton D. 29. Streptococcus. In: Manual of clinical microbiology. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. 8th ed., Washington, D.C. American Society for Microbiology Press, 2003;1:405-21.
• Douglas CWI, Heath J, Hampton KK and Preston FE. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol 1993;39:179-82.
• Whiley RA, Fraser H, Hardie JM and Beighton D. Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus and Streptococcus anginosus strains within the “Streptococcus milleri groups”. J Clin Microbiol 1990;28:1497-501.
• Westling K, Ljungman P, Thalme A and Julander I. Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital. Scand J Infect Dis 2002;34:316-9.
• Westling K, Julander I, Ljungman P, Heimdahl A, Thalme A and Nord CE. Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease. Clin Microbiol Infect 2004;10: 899-903.
• Bochud PY, Eggiman P, Calandra T, van Melle G, Saghafi L and Francioli P. Bacteremia due to viridans streptococci in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994;20:469-70.
• Beighton D, Carr AD and Oppenheim BA. Identification of viridans streptococci associated with bacteremia in neutropenic cancer patients. J Med Microbiol 1994;40:202-4.
• Jacobs JA, Schouten HC, Stobberingh EE and Soeters PB. Viridans streptococci isolated from bloodstream. Relevance of species identification. Diagn Microbiol Infect Dis 1995;22:267-73.
• Elting LS, Bodey GP and Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case control study of predisposing factors. Clin Infect Dis 1992;14:1201-7.
• Kerr KG, Armitage HT and McWhinney PH. Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy. Support Care Cancer 1999;7:28-30.
• Doern GV, Ferraro MJ, Brueggemann AB and Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996;40:891-4.
• Carratala J, Alcaide F, Fernandez- Sevilla A, Corbella X, Linares J and Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis 1995;20:1169-73.
• Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 2002;15: 613-30.
• Lenox JA and Kopczyk RA. A clinical system for scoring a patient's oral hygiene performance. J Am Dent Assoc 1973; 86:849-52.
• O'leary TJ, Drake RB and Naylor JE. The plaque control record. J Periodontol 1972;43:38.
• Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:610-6.
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-second Informational Supplement. January 2012. CLSI document M100-S22 Vol 32, No.3.
• Morita M, Kimura T, Kanegae M, Ishikawa A and Watanabe T. Reasons for extraction of permanent teeth in Japan. Commun Dent Oral Epidemiol 1994;22:303–6.
• Jovino-Silveira RC, Caldas Ade F Jr, de Souza EH and Gusmão ES. Primary reason for tooth extraction in a Brazilian adult population. Oral Health Prev Dent 2005;3(3):151-7.
• Ergin A, Eser ÖK and Hasçelik G. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases. New Microbiol 2011;34(2):187-93.
• Doern GV, Ferraro MJ, Brueggemann AB and Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996;40(4):891-4.
• Teng LJ, Hsueh PR, Chen YC, Ho SW and Luh KT. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother 1998;41(6):621-7.
• Rozkiewicz D et al. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population. Adv in Med Scien 2006;51(1):191-5.
• Chang, SC, Chen YC, Luh KT and Hsieh WC. Macrolides resistance of common bacteria isolated from Taiwan. Diagno Microbiol Infect Dis 1995;23:147–54.
• Hsueh PR, Chen HM, Lu YC and Wu JJ. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formosan Med Assoc 1996;95:29–36.
• Potgieter E, Carmichael M, Koornhof HJ and Chalkley LJ. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Europ J Clin Microbiol Infect Dis 1992;11: 543–6.
• Gomez-Garces JL, Alos JI and Cogollos R. Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group. Diagno Microbiol Infect Dis 1994; 19:69–73.

Vancouver

Dhotre S, Dharne M, Potdar S, Suklikar J, Suryawanshi N, Nagoba B. Viridians Group Streptococci in Patients Undergoing Tooth Extraction. EUR J GEN MED. 2015;12(3):227-33. https://doi.org/10.15197/ejgm.01406

APA

Dhotre, S., Dharne, M., Potdar, S., Suklikar, J., Suryawanshi, N., & Nagoba, B. (2015). Viridians Group Streptococci in Patients Undergoing Tooth Extraction. European Journal of General Medicine, 12(3), 227-233. https://doi.org/10.15197/ejgm.01406

AMA

Dhotre S, Dharne M, Potdar S, Suklikar J, Suryawanshi N, Nagoba B. Viridians Group Streptococci in Patients Undergoing Tooth Extraction. EUR J GEN MED. 2015;12(3), 227-233. https://doi.org/10.15197/ejgm.01406

Chicago

Dhotre, Shree, Mahesh Dharne, Shubhangi Potdar, Jaydeep Suklikar, Namdev Suryawanshi, and Basavraj Nagoba. "Viridians Group Streptococci in Patients Undergoing Tooth Extraction". European Journal of General Medicine 2015 12 no. 3 (2015): 227-233. https://doi.org/10.15197/ejgm.01406

Harvard

Dhotre, S., Dharne, M., Potdar, S., Suklikar, J., Suryawanshi, N., and Nagoba, B. (2015). Viridians Group Streptococci in Patients Undergoing Tooth Extraction. European Journal of General Medicine, 12(3), pp. 227-233. https://doi.org/10.15197/ejgm.01406

MLA

Dhotre, Shree et al. "Viridians Group Streptococci in Patients Undergoing Tooth Extraction". European Journal of General Medicine, vol. 12, no. 3, 2015, pp. 227-233. https://doi.org/10.15197/ejgm.01406